Discovery of a potential biomarker for immunotherapy of melanoma: PLAC1 as an emerging target.

Autor: Mahmoudi AR; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.; Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran., Ghods R; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran., Rakhshan A; Department of Pathology, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Madjd Z; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran., Bolouri MR; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Mahmoudian J; Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran., Rahdan S; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Shokri MR; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran., Dorafshan S; Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.; Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran., Shekarabi M; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Zarnani AH; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran.; Reproductive Immunology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran.; Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Jazyk: angličtina
Zdroj: Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2020 Dec; Vol. 42 (6), pp. 604-613. Date of Electronic Publication: 2020 Oct 26.
DOI: 10.1080/08923973.2020.1837865
Abstrakt: Background: Melanoma has increased in incidence worldwide prompting investigators to search for new biomarkers for targeted immunotherapy of this disease. Placenta specific 1 (PLAC1) is a new member of cancer-testis antigens with widespread expression in many types of cancer. Here, we aimed to study for the first time the expression pattern of PLAC1 in skin cancer samples including cutaneous melanoma, basal cell carcinoma (BCC), squamous cell carcinoma (SCC) in comparison to normal skin and nevus tissues and potential therapeutic effect of anti-PLAC1 antibody in melanoma cancer cell lines in vitro .
Materials and Methods: Polyclonal and monoclonal antibodies were applied for immunohistochemical profiling of PLAC1 expression using tissue microarray. The cytotoxic action of anti-PLAC1 antibody alone or as an antibody drug conjugate (with anti-neoplastic agent SN38) was investigated in melanoma cell lines.
Results: We observed that 100% (39 of 39) of melanoma tissues highly expressed PLAC1 with both cytoplasmic and surface expression pattern. Investigation of PLAC1 expression in BCC ( n  = 110) samples showed negative results. Cancer cells in SCC samples ( n  = 66) showed very weak staining. Normal skin tissues and nevus samples including congenital melanocytic nevus failed to express PLAC1. Anti-PLAC1-SN38 exerted a specific pattern of cytotoxicity in a dose- and time-dependent manner in melanoma cells expressing surface PLAC1.
Conclusions: Our findings re-inforce the concept of re-expression of embryonic/placental tissue antigens in cancer and highlight the possibility of melanoma targeted therapy by employing anti-PLAC1 antibodies. The data presented here should lead to the future research on targeted immunotherapy of patients with melanoma.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje